Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Kazia Therapeutics ( (KZIA) ).
On December 18, 2025, Kazia Therapeutics Limited regained compliance with Nasdaq’s continued listing standards by meeting the alternative minimum stockholders’ equity requirement of $2.5 million under Listing Rule 5550(b)(1), after previously being notified on November 12, 2025 that it had failed to satisfy the $35 million market value of listed securities threshold by November 10, 2025. As a result, a Nasdaq hearing that had been scheduled for January 8, 2026 to address potential suspension or delisting was cancelled, and Nasdaq confirmed that Kazia’s ADSs will continue trading on the Nasdaq Capital Market, removing an immediate overhang of listing risk for the company and its investors.
The most recent analyst rating on (KZIA) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Kazia Therapeutics stock, see the KZIA Stock Forecast page.
Spark’s Take on KZIA Stock
According to Spark, TipRanks’ AI Analyst, KZIA is a Underperform.
Kazia Therapeutics has a low overall stock score due to significant financial instability marked by declining revenues, negative equity, and cash flow issues. Technical indicators suggest bearish momentum, and poor valuation metrics reflect the company’s unprofitability. The absence of dividends and positive earnings call or corporate events data further emphasize the company’s challenges.
To see Spark’s full report on KZIA stock, click here.
More about Kazia Therapeutics
Kazia Therapeutics Limited is a biotechnology company listed on the Nasdaq Capital Market through American Depositary Shares (ADSs). The company operates in the life sciences sector, focusing on the development of therapeutic products, and is headquartered in Sydney, Australia.
Average Trading Volume: 723,765
Technical Sentiment Signal: Hold
Current Market Cap: $15.22M
For an in-depth examination of KZIA stock, go to TipRanks’ Overview page.